Clinical trial

Effectiveness of Sitagliptin for HIV Insulin Resistance and Inflammation

NCT01552694

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-10-01

PhasePHASE3

Study timeline

Study start (unknown)2012-10-01Date precision: month

Registry last updated2018-05-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Inflammationunresolved

Macrophage Infiltrationunresolved

Cardiovascular Diseaseunresolved

Interventions

SitagliptinDRUG · verified · RxNorm: sitagliptin

PlaceboDRUG

Sponsors & collaborators

Washington University School of Medicinelead sponsor

Mapped research locations

St LouisMissouri, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01552694 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.